Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details) - $ / shares		3 Months Ended	12 Months Ended
	Nov. 10, 2011	Mar. 31, 2016	Dec. 31, 2015
Expected life (in months)	60 months
Expected volatility	104.50%
Risk-free interest rate	0.875%
Exercise price	$ 0.81
Fair value per share	$ 0.54
Warrants Revalued at December 31, 2015 [Member]
Exercise price			$ 0.40
Fair value per share			$ 0.30
Warrants Revalued at December 31, 2015 [Member]
Expected life (in months)			11 months
Expected volatility			104.90%
Risk-free interest rate			0.65%
Exercise price			$ .25
Fair value per share			$ 0.16
Warrants Revalued at December 31, 2015 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)			55 months
Expected volatility			136.30%
Risk-free interest rate			1.29%
Warrants Revalued at December 31, 2015 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)			60 months
Expected volatility			141.60%
Risk-free interest rate			1.76%
Warrants Revalued at March 31, 2016 [Member]
Expected life (in months)		7 years
Expected volatility		103.60%
Risk-free interest rate		0.39%
Exercise price		$ 0.25
Fair value per share		$ 0.24
Warrants Revalued at March 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate		1.21%
Exercise price		$ 0.40
Fair value per share		$ 0.40
Warrants Revalued at March 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		48 months
Expected volatility		138.30%
Warrants Revalued at March 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		60 months
Expected volatility		142.20%
Issuance Fair Value [Member]
Expected life (in months)		24 months
Issuance Fair Value [Member] \| Minimum [Member]
Expected volatility		104.20%
Risk-free interest rate		0.05%
Exercise price		$ 0.28
Fair value per share		$ 0.09
Issuance Fair Value [Member] \| Maximum [Member]
Expected volatility		153.80%
Risk-free interest rate		0.99%
Exercise price		$ 0.35
Fair value per share		$ 0.30
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member]
Expected life (in months)		60 months
Exercise price		$ 0.40
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected volatility		118.30%
Risk-free interest rate		1.23%
Fair value per share		$ 0.19
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected volatility		138.30%
Risk-free interest rate		1.69%
Fair value per share		$ 0.40
Conversion Options Revalued at December 31, 2015 [Member]
Risk-free interest rate			1.06%
Exercise price			$ 0.28
Conversion Options Revalued at December 31, 2015 [Member] \| Minimum [Member]
Expected life (in months)			18 months
Expected volatility			112.20%
Fair value per share			$ 0.14
Conversion Options Revalued at December 31, 2015 [Member] \| Maximum [Member]
Expected life (in months)			24 months
Expected volatility			114.70%
Fair value per share			$ 0.33
Conversion Options Revalued at March 31, 2016 [Member]
Exercise price		$ 0.28
Conversion Options Revalued at March 31, 2016 [Member] \| Minimum [Member]
Expected life (in months)		12 months
Expected volatility		112.03%
Risk-free interest rate		0.59%
Fair value per share		$ 0.27
Conversion Options Revalued at March 31, 2016 [Member] \| Maximum [Member]
Expected life (in months)		24 months
Expected volatility		113.67%
Risk-free interest rate		0.73%
Fair value per share		$ 0.30